BENJAMIN DEVLIN-RUELLE: Open Payments
NPI 1598258477 · WYANDOTTE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$736 in 37 payments from 12 companies in 2025. Trend: 2023 $952 · 2024 $699 · 2025 $736
Food & beverage: $736
| Company | Payments | Amount |
|---|---|---|
| Exact Sciences Corporation | 9 | $187 |
| Orexo US, Inc. | 9 | $174 |
| Otsuka America Pharmaceutical, Inc. | 7 | $141 |
| Gilead Sciences, Inc. | 2 | $44 |
| Indivior Inc. | 2 | $35 |
| ABBVIE INC. | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 1 | $28 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $27 |
| Seqirus USA Inc | 1 | $17 |
| Braeburn Inc. | 1 | $17 |
Products named: Cologuard Collection Kit, Zubsolv, REXULTI, SUBLOCADE, MAVYRET, BREZTRI, CAPLYTA, Fluad.
Industry payments across MI — which companies pay providers there.
